241 related articles for article (PubMed ID: 19650179)
21. Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine.
Balakrishnan K; Wierda WG; Keating MJ; Gandhi V
Clin Cancer Res; 2005 Sep; 11(18):6745-52. PubMed ID: 16166456
[TBL] [Abstract][Full Text] [Related]
22. Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.
Campo S; Campo GM; Avenoso A; D'Ascola A; Musolino C; Calabrò L; Bellomo G; Quartarone E; Calatroni A
Biochimie; 2006 Dec; 88(12):1933-9. PubMed ID: 16938379
[TBL] [Abstract][Full Text] [Related]
23. Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
Rodriguez JM; Elias F; Montaner A; Flo J; Lopez RA; Zorzopulos J; Franco RJ; Lenial SP; Lopez Salón M; Pirpignani ML; Solimano J; Garay G; Riveros D; Fernandez J; Cacchione R; Dupont J
Medicina (B Aires); 2006; 66(1):9-16. PubMed ID: 16555722
[TBL] [Abstract][Full Text] [Related]
24. [Study of interleukins and their soluble receptors in B-cell chronic lymphatic leukemia].
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Pol Merkur Lekarski; 2004 Jan; 16(91):22-5. PubMed ID: 15074015
[TBL] [Abstract][Full Text] [Related]
25. [Interleukin-6 and interleukin-12 blood levels in patients with chronic B-cell lymphocytic leukemia].
Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
Pol Merkur Lekarski; 2004 Feb; 16(92):157-61. PubMed ID: 15176301
[TBL] [Abstract][Full Text] [Related]
26. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
[TBL] [Abstract][Full Text] [Related]
27. In vitro response of stimulated B-CLL lymphocytes of patients treated with Viscum album L. extracts.
Büssing A; Kochskämper H; Rieger S; Schierholz JM; Schlodder D; Schietzel M
Anticancer Res; 2007; 27(6B):4195-200. PubMed ID: 18225591
[TBL] [Abstract][Full Text] [Related]
28. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
29. Cell proliferation and death: forgotten features of chronic lymphocytic leukemia B cells.
Chiorazzi N
Best Pract Res Clin Haematol; 2007 Sep; 20(3):399-413. PubMed ID: 17707829
[TBL] [Abstract][Full Text] [Related]
30. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
[TBL] [Abstract][Full Text] [Related]
31. Predominantly post-transcriptional regulation of activation molecules in chronic lymphocytic leukemia: the case of transferrin receptors.
Chiotoglou I; Smilevska T; Samara M; Likousi S; Belessi C; Athanasiadou I; Stavroyianni N; Samara S; Laoutaris N; Vamvakopoulos N; Anagnostopoulos A; Fassas A; Stamatopoulos K; Kollia P
Blood Cells Mol Dis; 2008; 41(2):203-9. PubMed ID: 18621559
[TBL] [Abstract][Full Text] [Related]
32. South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients.
Gunawardana C; Austen B; Powell JE; Fegan C; Wandroo F; Jacobs A; Pratt G; Moss P
Br J Haematol; 2008 Aug; 142(4):606-9. PubMed ID: 18503582
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous in vitro apoptosis of de novo chronic lymphocytic leukemia cells correlates with risk of the disease progression.
Witkowska M; Nowak W; Cebula-Obrzut B; Majchrzak A; Medra A; Robak T; Smolewski P
Cytometry B Clin Cytom; 2014 Nov; 86(6):410-7. PubMed ID: 24515875
[TBL] [Abstract][Full Text] [Related]
34. Glutamate dehydrogenase activity in lymphocytes of B-cell chronic lymphocytic leukaemia patients.
Pajic T; Cernelc P; Sesek Briski A; Lejko-Zupanc T; Malesic I
Clin Biochem; 2009 Nov; 42(16-17):1677-84. PubMed ID: 19683518
[TBL] [Abstract][Full Text] [Related]
35. [Cytometric study of lymph node lymphocytes in patients with chronic lymphocytic leukemia and their prognostic significance].
Kolarović J
Med Pregl; 1991; 44(11-12):521-3. PubMed ID: 1821457
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
[TBL] [Abstract][Full Text] [Related]
37. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells.
Bueso-Ramos CE; Ferrajoli A; Medeiros LJ; Keating MJ; Estrov Z
Hematology; 2004 Aug; 9(4):279-86. PubMed ID: 15621735
[TBL] [Abstract][Full Text] [Related]
38. Monitoring antioxidant defenses and free radical production in space-flight, aviation and railway engine operators, for the prevention and treatment of oxidative stress, immunological impairment, and pre-mature cell aging.
De Luca C; Deeva I; Mariani S; Maiani G; Stancato A; Korkina L
Toxicol Ind Health; 2009; 25(4-5):259-67. PubMed ID: 19651796
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of cytoplasmic and nuclear shape of lymphocytes during progression of chronic lymphocytic leukemia.
Sawicki W; Strojny P; Rozycka M; Traczyk Z; Polkowska E
Anal Cell Pathol; 1989 Aug; 1(4):235-46. PubMed ID: 2487048
[TBL] [Abstract][Full Text] [Related]
40. A novel paradigm to trigger apoptosis in chronic lymphocytic leukemia.
Loeder S; Zenz T; Schnaiter A; Mertens D; Winkler D; Döhner H; Debatin KM; Stilgenbauer S; Fulda S
Cancer Res; 2009 Dec; 69(23):8977-86. PubMed ID: 19920200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
